Standards and new trends in the therapy of endometrial cancer;Management des endometrriumkarzinoms: Standards und neue trends

Gynakologe

Volumn 37, Issue 3, 2004, Pages 245-255

  Sehouli, J ^a   Lichtenegger, W ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Adjuvant treatment; Chemotherapy; Endometrial cancer; Irradiation; Treatment recommendations

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; MEDROXYPROGESTERONE ACETATE; PACLITAXEL; TAMOXIFEN;

BEAM THERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOTOXICITY; CLINICAL TRIAL; ENDOMETRIUM CANCER; FEMALE; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC CANCER; HUMAN; HYSTEROSCOPY; LEUKOPENIA; LIVER TOXICITY; MAJOR CLINICAL STUDY; NEUROTOXICITY; NEUTROPENIA; RADICAL HYSTERECTOMY; REVIEW; SURGICAL TECHNIQUE; TRANSVAGINAL ECHOGRAPHY; TREATMENT PLANNING;

EID: 2442675109     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00129-004-1497-8     Document Type: Review

References (41)

1. Aalders J, Abeler V, Kolstad P, Onsrud M (1987) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 56: 419-427
2. Announcements (1989) FIGO stages: 1988 revision. Gynecol Oncol 35: 125-126
3. Barakat RR (2002) Contemporary management of endometrial cancer. Am Soc Clin Oncol Educational Book, pp 85-88
4. Bauknecht T (1999) Prognosefaktoren beim Endometriumkarzinom. Onkologe 5: 396-402
5. Boronow RC, Morrow CP, Creasman WT et al. (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63: 825
6. Bremond A, Bataillard A, Thomas L et al. (2001) Standards, options and recommendations for the surgical management of carcinoma of the endometrium. Bull Cancer 88: 181-198
7. Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS (2002) Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 288: 1610-1621
8. Chuang L, Burke TW, Tornos C et al. (1995) Staging laparotomy for endomterial carcinoma: Assesment of retroperitoneal lymph nodes. Gynecol Oncol 58: 189-193
9. COSA-NZ-UK Endometrial Cancer Study Groups (1996) Pelvic lymphadenectomy in high risk endometrial cancer. Int J Gynecol Cancer 6: 102-107
10. Creasman WT, Morrow CP, Bundy BN et al. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 60 (Suppl): 2035-2041
11. Emons G (2002) Endometriumkarzinom. In: Sehouli J, Lichtenegger W (Hrsg) Update 2002/03. Chemotherapien in der Gynäkologischen Onkologie. Akademos
12. Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W (2000) Hormonal interactions in endometrial cancer. Endocr Relat Cancer 7: 227-242
13. Fanning J, Evans MC, Peters AJ et al. (1989) Endometrial adenocarcinoma histologic subtypes: clinical and pathologic profile. Gynecol Oncol 32: 288
14. Fleming GF, Brunetto LV, Burks RT et al. (2002) Randomized trial of doxorubicin (DOX) plus cisplatin (CIS) versus DOX plus CIS plus paclitaxel (TAX) in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group (GOG) study. Proceedings of ASCO Abstract 807
15. Gupta JK, Chien PF, Voit D, Clark TJ, Khan KS (2002) Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 81: 799-816
16. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R (1982) Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6: 93-108
17. Hoskins P, Swenerton K, Pike J, Wong F, Lim P, Aquino-Parsons C, Lee N (2001) Carboplatin/paclitaxel irradiation for advanced or recurrent endometrial cancer. Proceedings of ASCO Abstract 820
18. Deutsche Krebsgesellschaft, Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (2000) Interdisziplinäre kurzgefasste Leitlinien der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe. Endometriumkarzinom. Kurzgefasste Interdisziplinäre Leitlinien B22, S 287
19. Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11: 1531-1543
20. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F, Conner W (1995) Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56: 29-33
21. Kindermann G (1981) Zur Therapie des Endometriumkarzinoms. Geburtsh Frauenheilkd 41: 650
22. Larson DM, Broste SK, Krawisz BR (1998) Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 91: 335
23. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, Gadducci A (1998) An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 68: 274-279
24. Maggino T, Romagnolo C, Zola P, Sartori E, Landoni F, Gadducci A (1995) An analysis of approaches to the treatment of endometrial cancer in western Europe: a CTF study. Eur J Cancer 31: 1993-1997
25. Mariani A, Webb MJ, Keeney GL, Podratz KC (2001) Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 81: 100-104
26. Martin-Hirsch PL, Jarvis G, Kitchener H, Lilford R (2002) Progestagens for endometrial cancer (Cochrane Review). Cochrane Library 3
27. Maugeri G, Nardo LG, Campione C, Nardo F (2001) Endometrial lesions after tamoxifen therapy in breast cancer women. Breast J 7: 240-244
28. Obermair A, Geramou M, Gucer F et al. (1999) Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int J Gynecol Cancer 9: 383-386
29. Pecorelli S (1998) FIGO annual report on the result of treatment in gynaecological cancer, 23rd edn. J Epidemiol Biostat 3: 1-168
30. Podratz KC, Mariani A, Webb MJ (1998) Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol 70: 163-164
31. Randall ME, Brunetto G, Muss H et al. (2003) whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the Gynecologic Oncology Group. Proceedings of ASCO Abstract 3
32. Rose PG, Cha SD, Tak WK (1992) Radiation therapy for surgically proven paraaortic node metastasis in endometral carcinoma. Int Radiat Oncol Biol Phys 24: 229-233
33. Robert JA, Brunetto VL, Keys HM (1998 A phase III randomised study of surgery vs surgery plus adjuvant radiation in intermediate-risk endometrial adenocarcinoma (GOG no.99). Gynecol Oncol 68: 13S
34. Robert-Koch-Institut (2003) Schätzung der Krebsneuerkrankungen in Deutschland.http://www.rki.de/GBE/KREBS/KREBS.HTM
35. Sherman ME (2000) Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13: 295-308
36. Schmidt T, Romer T (2002) Sonography and hysteroscopy for endometrial carcinoma and its precursors. Zentralbl Gynakol 124: 20-26
37. Sehouli Ji, Camara O, Stengel D, Köhler G, Lichtenegger W (2003) Multizentrische Umfrage zum Stellenwert der Lymphonodektomie beim Endometriumkarzinom in Deutschland. Gynäkol Geburtshilf Rundschau 43: 104-110
38. Tamussino KF, Reich O, Gucer F, Moser F, Zivkovic F, Lang PF, Winter R (2000) Parametrial spread in patients with endometrial carcinoma undergoing radical hysterectomy. Int J Gynecol Cancer 10: 313-317
39. Thigpen JT, Blessing JA, DiSaia PJ, Yordan E, Carson LF, Evers C (1994) A randomized comparison of doxorubicin alone versus doxorubicin plus cyclophosphamide in the management of advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study. J Clin Oncol 12: 1408-1414
40. Trimble EL, Kosary C, Park RC (1999) Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 71: 340-343
41. Weidemann H, Hieronimus-Reichel A, Sehouli J et al. (2003) Multivisceral surgery for advanced gynaecological malignancies. Eur Surg 35: 102-105